Concurrent Management of a Patient with Toxic Epidermal Necrolysis and Coronavirus Disease-19: A Case Presentation

Çevik, Banu Ordu Macit Bombacı Elif Yakupoğlu Sezer Saraçoğlu Kemal Tolga

Toxic epidermal necrolysis (TEN) is a serious cutaneous adverse reaction with high mortality rate. The severe acute respiratory syndrome-coronavirus-2 virus disease represented a global pandemic known as coronavirus disease-2019 (COVID-19), without exact cure up to date. The usage of immunosuppressive drugs during COVID-19 infection is a major clinical challenge;however, it seems inevitable in rare cases. Here we aimed to report a patient, who was treated concomitantly for TEN and COVID-19 with a good clinical outcome by reviewing the existing literature. (English) [ABSTRACT FROM AUTHOR] Toksik epidermal nekroliz (TEN) yüksek mortalite ile seyreden ciddi bir kutanöz advers reaksiyondur. Şiddetli akut solunum sendromu-koronavirüs-2 virüsü tüm dünyayı etkisi altına alan bir pandemiye koronavirüs hastalığı-2019 (COVID-19) neden olmuş ve günümüze kadar kesin bir tedavi ortaya konamamıştır. COVID-19 tedavisinde immünosüpresif ilaçların kullanılması bir tartışma konusu olmakla beraber nadir olgularda kullanımı kaçınılmazdır. Burada, TEN ve COVID19’un eş zamanlı tedavi edilerek iyi sonuç alınan bir hastanın mevcut literatürler eşliğinde sunulması amaçlanmıştır. (Turkish) [ABSTRACT FROM AUTHOR] Copyright of Turkish Journal of Intensive Care is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)